Board of Directors

Meet The Board

Moncef Jendoubi, Ph.D

Founder & Chief Executive Officer
Read more

Founder/CEO

Dr. Jendoubi trained at the Pasteur Institute, where he held the position of Associate Professor. In 1987, he joined the National Institutes of Health (NIH) as Visiting Professor and became Chief of the Genetics and Molecular Immunology Section in 1990.
At the NIH, his research focused on cell-cell communication pathways. He has authored dozens of publications and holds several patents.
He holds an M.S. in Genetics, an M.S. in Biochemistry, a Ph.D. in Molecular Biology, a “Doctorat D’Etat Es Sciences” in Immunology, and a diploma in Bacteriology from the University of Paris.
  • Founder/CEO

    Dr. Jendoubi trained at the Pasteur Institute, where he held the position of Associate Professor. In 1987, he joined the National Institutes of Health (NIH) as Visiting Professor and became Chief of the Genetics and Molecular Immunology Section in 1990.
    At the NIH, his research focused on cell-cell communication pathways. He has authored dozens of publications and holds several patents.
    He holds an M.S. in Genetics, an M.S. in Biochemistry, a Ph.D. in Molecular Biology, a “Doctorat D’Etat Es Sciences” in Immunology, and a diploma in Bacteriology from the University of Paris.

Ana Petrovic

Director
Read more

Director

Ana Petrovic is the director of investments and chief operating officer at Pilatus Capital.  Prior to joining Pilatus Capital, Ana was a vice president on the life sciences deal team at Hercules Capital, a venture debt firm.  She joined Hercules Capital from Fluidigm Corporation, a life science tools company, where she was the director of corporate development and investor relations.  Before joining Fluidigm Corporation, she worked in investor relations strategy at Westwicke Partners, a strategic communications and capital markets advisory firm.  Prior to Westwicke Partners, Ana worked on Wall Street in sell-side equity research, most recently at Lazard Capital Markets, covering biotech equities.  Earlier in her career, Ana was a molecular biologist involved in HIV research at the National Institutes of Allergy and Infectious Diseases.  She has co-authored several articles published in scientific journals, including the Journal of Biomedical Medicine and the Journal of Virology.
Ana holds an MBA in finance and marketing from the University of Chicago, Booth School of Business, an MS in biochemistry from George Washington University, and a BS in microbiology from the University of Maryland.
  • Director

    Ana Petrovic is the director of investments and chief operating officer at Pilatus Capital.  Prior to joining Pilatus Capital, Ana was a vice president on the life sciences deal team at Hercules Capital, a venture debt firm.  She joined Hercules Capital from Fluidigm Corporation, a life science tools company, where she was the director of corporate development and investor relations.  Before joining Fluidigm Corporation, she worked in investor relations strategy at Westwicke Partners, a strategic communications and capital markets advisory firm.  Prior to Westwicke Partners, Ana worked on Wall Street in sell-side equity research, most recently at Lazard Capital Markets, covering biotech equities.  Earlier in her career, Ana was a molecular biologist involved in HIV research at the National Institutes of Allergy and Infectious Diseases.  She has co-authored several articles published in scientific journals, including the Journal of Biomedical Medicine and the Journal of Virology.
    Ana holds an MBA in finance and marketing from the University of Chicago, Booth School of Business, an MS in biochemistry from George Washington University, and a BS in microbiology from the University of Maryland.

David Teece, Ph.D

Chairman of the Board
Read more

Chairman of the Board

Serial entrepreneur and return-driven investor Dr. David Teece co-founded and built several enterprises from the ground up, growing cumulative annual exit revenues to over $1 billion. He has served as executive chairman and co-founder of Berkeley Research Group since 2010. Recognized as a leading authority globally on the management of innovation and business model design. He has also authored 200 books and articles on innovation and strategic management. While a part-time professor he has over 180,000 google scholar citations to his publications and the management of intellectual capital. Dr. Teece was recognized by Accenture as one of the world’s top-50 business intellectuals in 2011, inducted into the Thinkers50 Hall of Fame in 2020, and is one the #1 most-cited scholars in management and business.
David earned a PhD in economics from the University of Pennsylvania. He has received eight honorary PhDs; along with Royal honors. He serves or has served as an R&D Advisory Board Member at Saudi Aramco; Strategy Advisor at Intel; International Advisory Board Member at the Research Center for Technological Innovation at Tsinghua University; and advisory board member at Movac Venture Capital Fund.
 
  • Chairman of the Board

    Serial entrepreneur and return-driven investor Dr. David Teece co-founded and built several enterprises from the ground up, growing cumulative annual exit revenues to over $1 billion. He has served as executive chairman and co-founder of Berkeley Research Group since 2010. Recognized as a leading authority globally on the management of innovation and business model design. He has also authored 200 books and articles on innovation and strategic management. While a part-time professor he has over 180,000 google scholar citations to his publications and the management of intellectual capital. Dr. Teece was recognized by Accenture as one of the world’s top-50 business intellectuals in 2011, inducted into the Thinkers50 Hall of Fame in 2020, and is one the #1 most-cited scholars in management and business.
    David earned a PhD in economics from the University of Pennsylvania. He has received eight honorary PhDs; along with Royal honors. He serves or has served as an R&D Advisory Board Member at Saudi Aramco; Strategy Advisor at Intel; International Advisory Board Member at the Research Center for Technological Innovation at Tsinghua University; and advisory board member at Movac Venture Capital Fund.
     

Sebastien Belanger

Director
Read more

Director

Sebastien Belanger is the CEO & Co-Founder of Pilatus Capital. Sebastien also serves as the CEO, Chairman of the Board, and Co-Founder of Zēlos Energy. Prior to founding Pilatus Capital, Sebastien was Vice President & Head of Operations and Strategic Planning at Berkeley Research Group. Sebastien has held executive roles for several other enterprises, including as the CEO of World Mentor and Director of Strategic Planning, Acquisitions and Implementation for Law and Economics Consulting Group.
Sebastien holds a degree in Health Sciences from Grasset College, a bachelor’s degree in Mechanical Engineering decorated “On the Basis of Exceptional Qualities of Leadership, Dedication and Engineering Promise” as well as “Excellence in Engineering Design” from McGill University, and an MBA with distinction in Strategy and M&A from UCLA.
  • Director

    Sebastien Belanger is the CEO & Co-Founder of Pilatus Capital. Sebastien also serves as the CEO, Chairman of the Board, and Co-Founder of Zēlos Energy. Prior to founding Pilatus Capital, Sebastien was Vice President & Head of Operations and Strategic Planning at Berkeley Research Group. Sebastien has held executive roles for several other enterprises, including as the CEO of World Mentor and Director of Strategic Planning, Acquisitions and Implementation for Law and Economics Consulting Group.
    Sebastien holds a degree in Health Sciences from Grasset College, a bachelor’s degree in Mechanical Engineering decorated “On the Basis of Exceptional Qualities of Leadership, Dedication and Engineering Promise” as well as “Excellence in Engineering Design” from McGill University, and an MBA with distinction in Strategy and M&A from UCLA.

© Milagen. All rights reserved.

Dr. Jendoubi holds an M.S. in Genetics, an M.S. in Biochemistry, a Ph.D. in Molecular Biology, a “Doctorat D’Etat Es Sciences” in Immunology, and a diploma in Bacteriology from the University of Paris. He trained at the Pasteur Institute, where he held the position of Associate Professor. In 1987, he joined the National Institutes of Health (NIH) as Visiting Professor and became Chief of the Genetics and Molecular Immunology Section in 1990. At the NIH, his research focused on cell-cell communication pathways. He has authored dozens of publications and holds several patents.